Through
4/26
A round-up of Penn mentions in local, national, and international media.
Penn In the News
Ethan Craig of the Perelman School of Medicine discusses how immunosuppression medications can factor into personal risk calculations and the differences in potential risk based on the environment a person enters into.
Penn In the News
Researchers co-led by PIK Professor Michael Platt tracked the effects of Hurricane Maria on monkey populations to better understand how stress impacts humans. “The average monkey aged about two years biologically, so it’s about eight years of human life, which is pretty grim,” Platt said.
Penn In the News
Research led by Allison Lassiter of the Stuart Weitzman School of Design aims to identify water systems along the Atlantic and Gulf coasts that are vulnerable to saltwater intrusion. “Besides being unpleasant to drink, salinized water can harm vulnerable populations, including people with hypertension and pregnant women,” she said.
Penn In the News
A team led by Henry Daniell of the School of Dental Medicine used modified lettuce plants to produce a chewing gum that can trap the COVID-19 virus, preventing it from infecting cells in the mouth.
Penn In the News
Paulo Arratia of the School of Engineering and Applied Science commented on a study that explored how fluids flow under different pressures. “Visualizing flow inside a 3-D porous media literally gives a window into something that was impossible to see,” he said. “If you could actually see the molecules stretching and recoiling, that would be wonderful [to] connect the molecular point of view to the microscopic.”
Penn In the News
Katy Milkman of the Wharton School interviewed Ayelet Fishbach of the University of Chicago about the science of motivation.
Penn In the News
David Bozentka of the Perelman School of Medicine spoke about the physical effects of heavy smartphone usage. “I consider texting thumb as more of a repetitive stress injury,” he said.
Penn In the News
Jean Bennett and Albert Maguire of the Perelman School of Medicine developed a gene therapy to treat blindness in patients with retinal dystrophy caused by mutations in the RPE65 gene. “These people can now do things they never could have dreamed of doing, and they’re more independent and enjoying life,” said Bennett.
Penn In the News
Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage.
Penn In the News
Dorit Aviv of the Stuart Weitzman School of Design and international collaborators wrote an opinion piece about their work developing a healthier and more sustainable alternative to air conditioning.